Quality-of-life and asthma control with low-dose inhaled corticosteroids.
Guidelines are available to assist healthcare professionals in the appropriate management of patients with asthma, a highly prevalent and debilitating disease. Despite these guidelines many patients are still not being optimally treated, often resulting in poor asthma control and consequent impact on health-related quality of life (HRQoL). The present study concerns the findings of a multinational survey designed to evaluate the reported level of asthma control and HRQoL of patients with asthma. This analysis focuses on those patients receiving treatment with low-dose inhaled corticosteroids (ICS) alone. The findings confirm that many patients on a low-dose ICS alone are not receiving appropriate treatment to control their asthma, and this has a marked negative impact on their HRQoL. Revising management and treatment can improve asthma control and HRQoL for these patients, liberating them from the burden of this disease.
Roberts
June
J
Langworthy Medical Practice, Salford and Honorary Research Fellow, University of Aberdeen, Scotland, UK.
Williams
Angela
A
D000280:Administration, Inhalation; D000328:Adult; D018927:Anti-Asthmatic Agents / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001249:Asthma / Q000188:drug therapy / Q000523:psychology; D001294:Attitude to Health; D005060:Europe; D005194:Family Practice / Q000379:methods; D005260:Female; D019983:Guideline Adherence; D019538:Health Care Surveys; D006801:Humans; D008297:Male; D020380:Needs Assessment; D017410:Practice Guidelines as Topic; D011788:Quality of Life / Q000523:psychology; D012720:Severity of Illness Index; D011795:Surveys and Questionnaires; D016896:Treatment Outcome; D014481:United States
D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents